TACROLIMUS ANHYDROUS
Substance profile for UNII Y5L2157C4J, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 445643Substance Identity#
- UNII
- Y5L2157C4J
- Preferred term
- TACROLIMUS ANHYDROUS
- Registry number
- 104987-11-3
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C44H69NO12
Chemical And Database Identifiers#
- InChIKey
- QJJXYPPXXYFBGM-LFZNUXCKSA-N
- SMILES
- CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC
- RxCUI
- 235991
- PubChem
- 445643
- NCIt
- C76066
- INN ID
- 6878
DailyMed Socrata Ingredients#
Ingredient, Type, DailyMed label table| Ingredient | Type | DailyMed label | SPL version |
|---|
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | These highlights do not include all the information needed to use Tacrolimus Capsules USP safely and effectively. See full prescribing information for Tacrolimus Capsules USP. Tacrolimus Capsules USP Initial U.S. Approval 1994 Rx Only | 9 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | These highlights do not include all the information needed to use tacrolimus capsules safely and effectively. See full prescribing information for tacrolimus capsules. TACROLIMUS Capsules, USP for oral use Initial U.S. Approval: 1994 | 6 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | These highlights do not include all the information needed to use PROGRAF safely and effectively. See full prescribing information for PROGRAF. PROGRAF ® (tacrolimus) capsules, USP PROGRAF ® (tacrolimus) injection, (for intravenous use) Initial U.S. Approval: 1994 | 1 |
| anhydrous tacrolimus | ACTIVE INGREDIENT | PROGRAF® tacrolimus capsules tacrolimus injection (for intravenous infusion only) | 1 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE, GELATIN COATED [BRYANT RANCH PREPACK] | 1000 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | PROGRAF (TACROLIMUS) CAPSULE, GELATIN COATED PROGRAF (TACROLIMUS) INJECTION, SOLUTION [ASTELLAS PHARMA US, INC.] | 15 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [WATSON LABORATORIES, INC.] | 11 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | PROTOPIC (TACROLIMUS) OINTMENT [ASTELLAS PHARMA US INC.] | 10 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [SANDOZ INC] | 10 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | HECORIA (TACROLIMUS) CAPSULE [NOVARTIS PHARMACEUTICALS CORPORATION] | 7 |
| tacrolimus anhydrous | ACTIVE MOIETY | TACROLIMUS CAPSULE [DR. REDDY'S LABORATORIES LIMITED] | 7 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS OINTMENT [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 7 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [ACCORD HEALTHCARE INC.] | 5 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [AMERICAN HEALTH PACKAGING] | 5 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [CARDINAL HEALTH] | 5 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [STRIDES ARCOLAB LIMITED] | 5 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | ASTAGRAF XL (TACROLIMUS EXTENDED-RELEASE CAPSULES) CAPSULE, COATED, EXTENDED RELEASE [ASTELLAS PHARMA US, INC.] | 4 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [MYLAN PHARMACEUTICALS INC.] | 4 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | ENVARSUS XR (TACROLIMUS) TABLET, EXTENDED RELEASE [VELOXIS PHARMACEUTICALS, INC] | 3 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [CARDINAL HEALTH] | 2 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [MYLAN INSTITUTIONAL INC.] | 2 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS OINTMENT [PERRIGO NEW YORK INC] | 2 |
| TACROLIMUS ANHYDROUS | ACTIVE INGREDIENT | PROGRAF (TACROLIMUS) CAPSULE, GELATIN COATED [CARDINAL HEALTH] | 1 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [CARDINAL HEALTH] | 1 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [CARDINAL HEALTH] | 1 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [INGENUS PHARMACEUTICALS, LLC] | 1 |
| ANHYDROUS TACROLIMUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [KAISER FOUNDATION HOSPITALS] | 1 |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | TACROLIMUS CAPSULE [MAJOR PHARMACEUTICALS] | 1 |
pubchem.ncbi.nlm.nih.gov/compound/445643
mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=235991
ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C76066
precision.fda.gov/uniisearch/srs/unii/Y5L2157C4J